How does that deal work? LPC buying the rest of these shares now? Jason ought to give them a call about their share value. Maybe they can work up a pumping article together.
There appears to be a lot of shares traded between 1.25 and 1.35. Short volume?
Thats right, I feel they really have to be flexible now and will strike a deal. Exalgo is nothing. It really comes down to CHTS and Z944. Maybe some patents also could be worth 10 or so million. Definitely above this price.
I really don't know. It could be anywhere from 50MM to 125MM if someone is pleased with the LEP data. They also have the Novartis partnership thats been brewing for 5-6 years and is also valuable. Management is really pressured now to do something and I think they have been thinking about this happening and have planned for it.
30, 40, 50MM? That is why Z944 is valuable, plus the company has net cash of $15MM at this point. ADD 40MM FOR Z944 and you you should achieve a 55MM market cap at minimum.
I think a minimal of 50MM Z944 is worth depending on who is interested. That is why they did the LEP testing which did not cost alot, but gave them a card to play.
They won't go bankrupt if both fail. A sale of the company would be their option as Corrigan indicated. They still have Z944 that has already shown it works with the LEP testing, along with all the patents and collaborative work with Novartis, Amgen, Esai. They could be bought up between 60M-150MM depending on who it is. A fall to 2 as JN indicated would put the company at a 44MM market cap. A buyout between 2 and 5 might work but it could go a bit higher if there is someone that wants to further develop Z944 and Z160.
That right on. Just the way it is. I think it bounces back tomorrow and shorts are caught. This was a trap for them to begin with. Wall at knew there was a response to any revenue miss and they will justify it. Will the ticket monster be accretive to earnings? Give this stock a PE and who knows where it goes
Yes a small miss in revenues but diversifying revenue streams with a better than expected profit. They are giving Wall Street what they want but it comes at an expense. We'll see tomorrow if they really like what they hear.
maybe its a good sign then. If you think about why would he say this now when he has had a year to say it. Playing the short side?